OncoPep
Dr. Klinman served as a principal investigator at the National Cancer Institute, NIH and the Center for Biologics of the FDA. His scientific expertise spans the fields of vaccinology, cancer immunotherapy and autoimmunity, having published over 350 articles in those areas.
This person is not in the org chart
This person is not in any offices
OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.